Ibrolipim - CISMeF

Preferred Label : Ibrolipim;

NCIt definition : A lipoprotein lipase (LPL) activator with antihyperlipidemic activity. Activation of LDL by ibrolipim lowers plasma triglycerides, with a concomitant elevation of high-density lipoprotein cholesterol.;

UNII : 07H1561618;

InChIKey : KPRTURMJVWXURQ-UHFFFAOYSA-N;

CAS number : 133208-93-2;

Molecule name : NO-1886;

Chemical formula : C19H20BrN2O4P;

Détails

Origin ID

C75256;

UMLS CUI

C2697658;

Automatic exact mappings (from CISMeF team)
- 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- ibrolipim [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ibrolipim [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients